about
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementiaStimulus-dependent central processing of auditory stimuli: a PET study.Early microgliosis precedes neuronal loss and behavioural impairment in mice with a frontotemporal dementia-causing CHMP2B mutationDementia with impaired temporal glucose metabolism in late-onset metachromatic leukodystrophy.Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations.FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.Presymptomatic cerebral blood flow changes in CHMP2B mutation carriers of familial frontotemporal dementia (FTD-3), measured with MRI.Long-term cholinesterase inhibitor treatment of Alzheimer's disease.Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology.Brain energy metabolism and blood flow differences in healthy aging.The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium.Frontotemporal dementia caused by CHMP2B mutations.EFNS task force: the use of neuroimaging in the diagnosis of dementia.Frequency and severity of semantic deficits in a consecutive memory clinic cohort.The frequency and influence of dementia risk factors in prodromal Alzheimer's disease.Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI).Development of a dementia assessment quality database.Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer's Disease: A Randomized Controlled Trial.TMEM106B and ApoE polymorphisms in CHMP2B-mediated frontotemporal dementia (FTD-3).Effect of aerobic exercise on physical performance in patients with Alzheimer's disease.Early-Onset Dementia: Frequency, Diagnostic Procedures, and Quality Indicators in Three European Tertiary Referral Centers.Cortical responses to sustained and divided attention in Alzheimer's disease.Positron emission tomography of cortical centers of tinnitus.Preserving cognition, quality of life, physical health and functional ability in Alzheimer's disease: the effect of physical exercise (ADEX trial): rationale and design.Activation of human extrageniculostriate pathways after damage to area V1.Origin of human motor readiness field linked to left middle frontal gyrus by MEG and PET.Cortical sites of sustained and divided attention in normal elderly humans.Presymptomatic generalized brain atrophy in frontotemporal dementia caused by CHMP2B mutation.Cerebral metabolic response to low blood flow: possible role of cytochrome oxidase inhibition.Cognitive impairment in the preclinical stage of dementia in FTD-3 CHMP2B mutation carriers: a longitudinal prospective study.Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's disease.Usability of cerebrospinal fluid biomarkers in a tertiary memory clinic.The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease.Cerebral blood-flow changes evoked by two levels of painful heat stimulation: a positron emission tomography study in humans.Cortical volumes and atrophy rates in FTD-3 CHMP2B mutation carriers and related non-carriersA Reassessment of the Neuropathology of Frontotemporal Dementia Linked to Chromosome 3Cerebral functional anatomy of voluntary contractions of ankle muscles in manCerebral activation during bicycle movements in manFrontotemporal dementia linked to chromosome 3
P50
Q24309521-97CA5ED0-180F-44C9-A14B-C9D7F011D4A5Q30322962-19A6207E-14F4-4532-95C9-7F089F4744F0Q30847257-57AF94C3-5711-4CCE-8E2C-281F360911C2Q30847257-C943ABF5-E104-4068-8365-F043C3BFB45FQ31927444-AC34657A-F5F9-409F-B609-725B1627C86FQ33832871-EF01FD4D-1585-4700-BC4E-BC5A925E22A9Q33922335-B42677E2-365A-4698-8052-F705AB399979Q35800785-36E968EE-A53B-4BDC-9E95-FDE8FED2419DQ35838234-33589DA0-A43E-4B98-9B64-90D00DC56AE6Q35891535-E0355A5D-9109-4CA7-9871-596AFC9AF15FQ36073666-C3445B3F-F0E2-4282-935C-6655139E46AAQ36079316-D555DEAB-F9C2-4887-9B21-4365F9B31689Q37133754-10BBD261-4322-4638-BE97-A5728337288BQ37827517-4542F042-602C-4EA5-B256-62DC26E025BAQ38035398-C17D41DF-48E4-4B15-A79F-FDF56D496080Q38432215-9A659C95-115C-436E-9B46-9A75E7F045CDQ38686461-3282C212-8A15-464B-B55D-68F8FBA103E8Q39969682-3141695C-8D87-42F1-BB8F-90F4D41F7096Q44553857-D1E4C862-B546-4C62-B938-8FF2267DEA5BQ46275055-E941B4A9-6836-45CB-A8A1-9238ABD7805BQ47625837-E2E2E684-67E0-4765-809C-8DFC1561D04EQ47715031-9A98CDA6-E243-4651-8EBA-39CDB91BBACAQ47802998-76B01838-06A3-4790-BB91-775EC173BEB2Q48129700-A5E5641B-589D-4021-8649-93285E0352AEQ48132956-29B56822-06E8-404C-85C0-D04D16A38767Q48150029-6C20CD1B-247F-4A41-BB25-7B43ADEDC27FQ48299476-24836C31-E2AC-4B7C-A006-AEAA568A5753Q48394089-56630CDA-DA27-4244-8B70-FAF6FCC9896AQ48606976-7A090709-B77C-41A7-B01D-9A254EE5242BQ48760857-9B591C0D-8223-4E77-A154-3866AE6C9E18Q48939371-D3D20402-5900-475B-9C2F-13D151B6F30BQ50776156-5E420A94-8B81-472D-B4D9-927A50D52BEDQ51919331-1EFDCD2D-80CE-4BB6-9D00-2EEDC14C89EDQ51964228-FE4FC090-E18C-410E-A17A-A4036664AB94Q53292933-344192B2-1A95-46F4-83EC-7F9CC4C87245Q53338653-4A7748A8-D098-4DEB-AFF8-2AE96CD020B5Q60483459-A82C5387-69B7-4AB6-97DF-890564C16053Q60597019-2AD0AB89-AB64-48AD-9C48-2086DCC15BC3Q61630583-E67C0A0D-8FEF-4223-9EE3-6CF262C451C1Q61630599-3D6138CF-3C0D-47F8-9A36-A9FC76DC56EB
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Peter Johannsen
@ast
Peter Johannsen
@en
Peter Johannsen
@es
Peter Johannsen
@nl
Peter Johannsen
@sl
type
label
Peter Johannsen
@ast
Peter Johannsen
@en
Peter Johannsen
@es
Peter Johannsen
@nl
Peter Johannsen
@sl
prefLabel
Peter Johannsen
@ast
Peter Johannsen
@en
Peter Johannsen
@es
Peter Johannsen
@nl
Peter Johannsen
@sl
P1053
G-1079-2011
P106
P108
P1153
7003447121
P21
P31
P3829
P496
0000-0002-0528-1070